GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acadia Pharmaceuticals Inc. (ACAD) [hlAlert]

Rating:
Sell ACAD
down 95.33 %

Acadia Pharmaceuticals Inc. (ACAD) downgraded to Sell by Citigroup

Posted on: Tuesday,  Sep 1, 2009  9:25 AM ET by Citigroup

Citigroup rated Sell Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) on 09/01/2009, when the stock price was $1.77. Since
then, Acadia Pharmaceuticals Inc. has gained 2041.81% as of 01/25/2016's recent price of $37.91.
If you would have followed this Citigroup's recommendation on ACAD, you would have lost 95.33% of your investment in 2337 days.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is developing a portfolio consisting of its four product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson?s disease psychosis. In addition, the Company has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc., and ACP-106 in IND-track development. The Company?s product candidates include Pimavanserin, AGN-XX/YY, AC-262271 and ACP-106. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/1/2009 9:25 AM Sell
None
1.77
as of 12/31/2009
1 Week down  -23.70 %
1 Month down  -35.77 %
3 Months up  2.33 %
1 YTD up  5.64 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/2/2007 9:25 AM Hold
None
14.96 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy